ASPN vs ROMA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits severe financial distress with a Piotroski F-Score of just 2/9, indicating weak financial health. Despite a strong current ratio and low debt/equity, profitability is deeply negative, with a profit margin of -86.52% and ROE of -75.06%. Revenue has collapsed by 37.8% year-over-year, and while recent quarters show erratic earnings surprises, the long-term trend is one of deterioration. The stock trades significantly below its 52-week high with a bearish technical trend and negative insider sentiment, reinforcing fundamental weaknesses.
ROMA exhibits a Piotroski F-Score of 4/9, indicating stable but mediocre financial health, which is heavily contradicted by catastrophic operating margins of -500.84%. The company is trading at an extreme valuation premium with a Price/Book ratio of 29.55 and Price/Sales of 25.04, despite negative ROE and ROA. While the 1-year price performance is exceptionally strong (+415.9%), this appears to be a speculative rally disconnected from fundamental value. The combination of severe losses and a bearish technical trend suggests a high risk of correction.
Compare Another Pair
Related Comparisons
ASPN vs ROMA: Head-to-Head Comparison
This page compares Aspen Aerogels, Inc. (ASPN) and Roma Green Finance Limited (ROMA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.